Work

120MO Prognostic value of immune gene-expression signatures (iGES) vs tumor-infiltrating lymphocytes (TILs) in early-stage HER2+ breast cancer: A combined analysis of CALGB 40601 (C40601) and PAMELA trials

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.401

Authors: A. Fernandez-Martinez, T. Pascual, B. Singh, P. Nuciforo, K.A. Hoadley, N.U. Rashid, P.A. Spears, N. Chic, I. Krop, D. Hillman, A. Partridge, A. Prat, L.A. Carey, C.M. Perou

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Hospital Clínic de Barcelona, Solti, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, White Plains Hospital, Vall d'Hebron Institute of Oncology, Dana-Farber Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3203660105

FWCI: 0.165

Cites:

Cited by: 2

Related to: 10